Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roxana Rustomjee

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
The Lancet. Infectious Diseases|May 10, 2014
Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trialSayoki G Mfinanga, Bruce J Kirenga, Duncan M Chanda, et al.
American Journal of Respiratory and Critical Care Medicine|October 19, 2018
Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis InfectionSalmaan Keshavjee, Farhana Amanullah, Adithya Cattamanchi, et al.
Plos Pathogens|October 13, 2022
An introduction to the Marburg virus vaccine consortium, MARVACRobert W Cross, Ira M Longini, Stephan Becker, et al.
Nature Reviews. Drug Discovery|July 18, 2015
Towards host-directed therapies for tuberculosisAlimuddin Zumla, Markus Maeurer, , et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
The Lancet. Infectious Diseases|May 10, 2014
Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trialSayoki G Mfinanga, Bruce J Kirenga, Duncan M Chanda, et al.
American Journal of Respiratory and Critical Care Medicine|October 19, 2018
Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis InfectionSalmaan Keshavjee, Farhana Amanullah, Adithya Cattamanchi, et al.
Plos Pathogens|October 13, 2022
An introduction to the Marburg virus vaccine consortium, MARVACRobert W Cross, Ira M Longini, Stephan Becker, et al.
Nature Reviews. Drug Discovery|July 18, 2015
Towards host-directed therapies for tuberculosisAlimuddin Zumla, Markus Maeurer, , et al.
Pageof 5